BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 31100227)

  • 1. Satisfaction with Care Among Men with Localised Prostate Cancer: A Nationwide Population-based Study.
    Bergengren O; Garmo H; Bratt O; Holmberg L; Johansson E; Bill-Axelson A
    Eur Urol Oncol; 2018 May; 1(1):37-45. PubMed ID: 31100227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of Life after Radical Prostatectomy or Watchful Waiting With or Without Androgen Deprivation Therapy: The SPCG-4 Randomized Trial.
    Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Bill-Axelson A;
    Eur Urol Oncol; 2018 Jun; 1(2):134-142. PubMed ID: 31100237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer.
    Bratt O; Folkvaljon Y; Hjälm Eriksson M; Akre O; Carlsson S; Drevin L; Franck Lissbrant I; Makarov D; Loeb S; Stattin P
    Eur Urol; 2015 Jul; 68(1):53-8. PubMed ID: 25813688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate Cancer Death After Radiotherapy or Radical Prostatectomy: A Nationwide Population-based Observational Study.
    Robinson D; Garmo H; Lissbrant IF; Widmark A; Pettersson A; Gunnlaugsson A; Adolfsson J; Bratt O; Nilsson P; Stattin P
    Eur Urol; 2018 Apr; 73(4):502-511. PubMed ID: 29254629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants for choosing and adhering to active surveillance for localised prostate cancer: a nationwide population-based study.
    Bergengren O; Garmo H; Bratt O; Holmberg L; Johansson E; Bill-Axelson A
    BMJ Open; 2019 Dec; 9(12):e033944. PubMed ID: 31874896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term Psychological and Quality-of-life Effects of Active Surveillance and Watchful Waiting After Diagnosis of Low-risk Localised Prostate Cancer.
    Egger SJ; Calopedos RJ; O'Connell DL; Chambers SK; Woo HH; Smith DP
    Eur Urol; 2018 Jun; 73(6):859-867. PubMed ID: 28851582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could Differences in Treatment Between Trial Arms Explain the Reduction in Prostate Cancer Mortality in the European Randomized Study of Screening for Prostate Cancer?
    Carlsson SV; Månsson M; Moss S; Kwiatkowski M; Recker F; Tammela TLJ; Bangma C; Roobol MJ; Auvinen A; Hugosson J
    Eur Urol; 2019 Jun; 75(6):1015-1022. PubMed ID: 30928162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011.
    Evans SM; Millar JL; Davis ID; Murphy DG; Bolton DM; Giles GG; Frydenberg M; Andrianopoulos N; Wood JM; Frauman AG; Costello AJ; McNeil JJ
    Med J Aust; 2013 Jun; 198(10):540-5. PubMed ID: 23725268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance.
    Goh AC; Kowalkowski MA; Bailey DE; Kazer MW; Knight SJ; Latini DM
    BJU Int; 2012 Jul; 110(2 Pt 2):E50-6. PubMed ID: 22145791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery.
    Tosoian JJ; Sundi D; Trock BJ; Landis P; Epstein JI; Schaeffer EM; Carter HB; Mamawala M
    Eur Urol; 2016 Apr; 69(4):576-581. PubMed ID: 26456680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immediate versus delayed prostatectomy: Nationwide population-based study (.).
    Loeb S; Folkvaljon Y; Robinson D; Makarov DV; Bratt O; Garmo H; Stattin P
    Scand J Urol; 2016 Aug; 50(4):246-54. PubMed ID: 27067998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.
    Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Ruutu M; Bill-Axelson A;
    Lancet Oncol; 2011 Sep; 12(9):891-9. PubMed ID: 21821474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-Based Assessment of Determining Treatments for Prostate Cancer.
    Chamie K; Williams SB; Hu JC
    JAMA Oncol; 2015 Apr; 1(1):60-7. PubMed ID: 26182305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life in active surveillance and radical prostatectomy for low-risk prostate cancer: a prospective observational study (HAROW - Hormonal therapy, Active Surveillance, Radiation, Operation, Watchful Waiting).
    Ansmann L; Winter N; Ernstmann N; Heidenreich A; Weissbach L; Herden J
    BJU Int; 2018 Sep; 122(3):401-410. PubMed ID: 29603553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Affecting Satisfaction with the Decision-Making Process and Decision Regret for Men with a New Diagnosis of Prostate Cancer.
    Skyring TA; Mansfield KJ; Mullan JR
    Am J Mens Health; 2021; 15(4):15579883211026812. PubMed ID: 34261353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term distress after radical prostatectomy versus watchful waiting in prostate cancer: a longitudinal study from the Scandinavian Prostate Cancer Group-4 randomized clinical trial.
    Bill-Axelson A; Garmo H; Holmberg L; Johansson JE; Adami HO; Steineck G; Johansson E; Rider JR
    Eur Urol; 2013 Dec; 64(6):920-8. PubMed ID: 23465517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When Primary Care Providers (PCPs) Help Patients Choose Prostate Cancer Treatment.
    Radhakrishnan A; Grande D; Ross M; Mitra N; Bekelman J; Stillson C; Pollack CE
    J Am Board Fam Med; 2017; 30(3):298-307. PubMed ID: 28484062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received.
    Neal DE; Metcalfe C; Donovan JL; Lane JA; Davis M; Young GJ; Dutton SJ; Walsh EI; Martin RM; Peters TJ; Turner EL; Mason M; Bryant R; Bollina P; Catto J; Doherty A; Gillatt D; Gnanapragasam V; Holding P; Hughes O; Kockelbergh R; Kynaston H; Oxley J; Paul A; Paez E; Rosario DJ; Rowe E; Staffurth J; Altman DG; Hamdy FC;
    Eur Urol; 2020 Mar; 77(3):320-330. PubMed ID: 31771797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying the Transition from Active Surveillance to Watchful Waiting Among Men with Very Low-risk Prostate Cancer.
    Van Hemelrijck M; Garmo H; Lindhagen L; Bratt O; Stattin P; Adolfsson J
    Eur Urol; 2017 Oct; 72(4):534-541. PubMed ID: 27816297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why patients choose prostatectomy or brachytherapy for localized prostate cancer: results of a descriptive survey.
    Hall JD; Boyd JC; Lippert MC; Theodorescu D
    Urology; 2003 Feb; 61(2):402-7. PubMed ID: 12597956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.